Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Glucagon-like peptide 1 receptor agonists (GLP-1s) are on track to become one of the largest drug classes in history, driven by demand for weight loss alternatives and the potential of GLP-1s to treat a range of conditions such as diabetes, cardiovascular risk, liver disease, and dementia
As 2024 drew to a close, Englands NICE finalised its guidance for Mounjaro, recommending its use in the primary care setting, for treating adults with a body mass index (BMI) 35 kg/m2 and at least one weight-related co-morbidity, alongside a reduced-calorie diet and increased exercise, with no restriction on treatment duration, equating to a total eligible population of 3.4 million patients [5]
The results showed that NAC provided minor improvements in pregnancy and ovulation rates compared to other treatments like metformin when used to treat unexplained infertility
Backed by Motorsport Australia
If youd like to learn more about the link between back pain and weight loss after medications like Wegovy, connect with our Hiram chiropractor at Cornerstone Chiropractic for support
